Quick10K

⚲

Virtus Investment Partners

Filings

10-Q	2021-03-31	Filed 2021-05-06
10-K	2020-12-31	Filed 2021-02-26
10-Q	2020-09-30	Filed 2020-11-05
10-Q	2020-06-30	Filed 2020-08-06
10-Q	2020-03-31	Filed 2020-05-06
10-K	2019-12-31	Filed 2020-02-27
10-Q	2019-09-30	Filed 2019-11-06
10-Q	2019-06-30	Filed 2019-08-06
10-Q	2019-03-31	Filed 2019-05-06
10-K	2018-12-31	Filed 2019-02-27
10-Q	2018-09-30	Filed 2018-11-08
10-Q	2018-06-30	Filed 2018-08-08
10-Q	2018-03-31	Filed 2018-05-08
10-K	2017-12-31	Filed 2018-02-27
10-Q	2017-09-30	Filed 2017-11-06
10-Q	2017-06-30	Filed 2017-08-08
10-Q	2017-03-31	Filed 2017-05-08
10-K	2016-12-31	Filed 2017-02-27
10-Q	2016-09-30	Filed 2016-11-07
10-Q	2016-06-30	Filed 2016-08-09
10-Q	2016-03-31	Filed 2016-05-03
10-K	2015-12-31	Filed 2016-02-24
10-Q	2015-09-30	Filed 2015-10-30
10-Q	2015-06-30	Filed 2015-07-31
10-Q	2015-03-31	Filed 2015-05-11
10-K	2014-12-31	Filed 2015-03-02
10-Q	2014-09-30	Filed 2014-11-07
10-Q	2014-06-30	Filed 2014-07-29
10-Q	2014-03-31	Filed 2014-05-07
10-K	2013-12-31	Filed 2014-02-24
10-Q	2013-09-30	Filed 2013-11-04
10-Q	2013-06-30	Filed 2013-08-02
10-Q	2013-03-31	Filed 2013-05-07
10-K	2012-12-31	Filed 2013-03-01
10-Q	2012-09-30	Filed 2012-11-07
10-Q	2012-06-30	Filed 2012-08-07
10-Q	2012-03-31	Filed 2012-05-08
10-K	2011-12-31	Filed 2012-03-01
10-Q	2011-09-30	Filed 2011-11-04
10-Q	2011-06-30	Filed 2011-08-05
10-Q	2011-03-31	Filed 2011-05-05
10-K	2010-12-31	Filed 2011-03-01
10-Q	2010-09-30	Filed 2010-11-04
10-Q	2010-06-30	Filed 2010-08-06
10-Q	2010-03-31	Filed 2010-05-04
10-K	2009-12-31	Filed 2010-03-08

Reports

8-K	2020-10-23
8-K	2020-07-24
8-K	2020-07-04
8-K	2020-05-18
8-K	2020-05-01
8-K	2020-02-09
8-K	2020-01-31
8-K	2020-01-09
8-K	2019-10-25
8-K	2019-09-29
8-K	2019-07-26
8-K	2019-05-15
8-K	2019-04-26
8-K	2019-04-10
8-K	2019-02-01
8-K	2018-10-26
8-K	2018-07-27
8-K	2018-07-02
8-K	2018-06-11
8-K	2018-05-15
8-K	2018-04-27
8-K	2018-03-26
8-K	2018-02-15
8-K	2018-02-14
8-K	2018-02-07
8-K	2018-02-02

Virtus Investment Partners Financials

VRTS Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin


Comps ($MM TTM)	Market Cap	Gross Margin	EV/EBITDA	Ret on Assets	Assets	Liabilities	Revenue	G Profit	Net Income	EBITDA	EV
ENETI INC. (NETI)
024 Pharma (EEIG)
Vivus (VVUS)	41	77%	-17.5	-11%	226	289	73	56	-25	-14	243
Clovis Oncology (CLVS)	219	0%	-0.0	-56%	717	804	134	0	-400	-394	18
Cementos Pacasmayo Saa (CPAC)	4,145			0%	2,863	1,412	0	0	0	0	4,145
11 Good Energy (ELVN)
Exantas Capital (XAN)
1347 Capital Corp (TFSC)
Bancorp of New Jersey (BKJ)	123		1.0	0%	962	869	0	0	3	15	14
1PM Industries (OPMZ)
1st Century Bancshares (FCTY)
1st Financial Services Corp (FFIS)
1st United Bancorp (FUBC)
2-Track Global (TTG)
ENTERGY ARKANSAS, LLC (EAI)
21st Century Oncology Holdings (RTSX)
24Holdings (TWFH)
30DC (TDCH)
3D Pioneer Systems (DPSM)
ALABAMA POWER CO (APRCP)


Balance Sheet ($MM)	2011-06-30	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Cash	37	39	45	33	49	43		46	71	245	272	237	171	174	203	168	196	143	108	67	248	179	83	252	179	386	233	136	181	220	255	198	251	279
Accounts Receivable	25	26	27	31	33	33	37	42	45	47	50	54	54	53	50	53	43	40	39	38	36	37	36	38	59	62	66	63	68	80	70	74	72	74
Inventory
PP&E	6	6	5	7	7	7	16	8	8	7	17	7	8	7	19	9	9	9	24	9	8	8	25	7	12	12	31	11	11	12	44	20	20	19
Assets	151	151	286	278	287	312	333	315	343	602	645	586	641	696	699	680	722	827	860	781	975	930	824	1,013	2,292	2,742	2,591	2,538	2,690	2,884	2,871	2,845	3,067	3,113
Accounts Payable	6	4	5	6	6	7	8	9	10	11
Long-Term Debt	15	15	15	15	15	15	15	15	15		0							9	153	155	0	0	30	0	248	249		245	245	339		318	306	292
Liabilities	63	68	68	54	60	75	85	67	77	117	110	72	116	113	112	80	107	238	276	235	482	429	465	416	1,645	2,074	1,981	1,909	2,046	2,165	2,169	2,140	2,343	2,344
Stockholders' Equity	53	48	183	224	226	237	244	245	256	466	493	510	515	561	564	565	559	540	510	506	466	470	322	552	574	584	589	609	624	644	630	634	651	666


Income Statement ($MM)	2011-06-30	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Revenue	49	55	56	62	74	72	79	86	110	100	106	108	120	118	112	104	100	92	86	80	80	82	80	80	94	124	128	129	133	152	138	131	140	146
Cost of Revenue
Gross Profit
R&D
SG&A						0	0	0	0
Tax	0	0	-0	4	10	7	-16	8	9	13	14	14	14	-2	15	11	8	10	9	8	6	7	1	4	2	10	25	7	9	7		4	9	11
Net Income	3	-3	141	5	17	12	-28	14	17	21	27	22	20	37	18	20	9	-4	6	12	9	16	12	14	0	21	5	24	23	28	1	22	28	25


Cash Flow ($MM)	2011-06-30	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Cash Operating		7	17	-9	26	-2	25	-5	28	4	3	-33	-58	-11	43	-25	26		-152	-38	90	-53	32	-15	70	-158	-79	-62	-93	53		-23	-120	41
Cash Investing		-0	-3	-2	-1	-1	-2	-2	-4	-0	-0	-1	-1	-5	-1	-1	-3		-1	-1	8	-2	-2	5	-394	-0	-28	-22	37	-127		-2	-4	19
Cash Financing		-4	-8	-1	-9	-3	-3	-11	1	170	24	-0	-8	20	-13	-9	4		122	2	90	-13	-127	179	252	366	-46	-14	100	114		-31	177	-32